The therapeutic effects of MSc1 nanocomplex, synthesized by nanochelating technology, on experimental autoimmune encephalomyelitic C57/BL6 mice

PURPOSE: Currently approved therapies for multiple sclerosis (MS) at best only slow down its progression. Therefore, it is necessary to utilize novel technologies in order to synthesize smart multifunctional structures. In the present study, for the first time we evaluated the therapeutic potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Fakharzadeh, Saideh, Sahraian, Mohammad Ali, Hafizi, Maryam, Kalanaky, Somayeh, Masoumi, Zahra, Mahdavi, Mehdi, Kamalian, Nasser, Minagar, Alireza, Nazaran, Mohammad Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137990/
https://www.ncbi.nlm.nih.gov/pubmed/25143732
http://dx.doi.org/10.2147/IJN.S64630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4137990/
https://www.ncbi.nlm.nih.gov/pubmed/25143732
http://dx.doi.org/10.2147/IJN.S64630

Ejemplares similares